SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001723128-22-000006
Filing Date
2022-03-01
Accepted
2022-03-01 16:45:44
Documents
155
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrx-20211231.htm   iXBRL 10-K 4108927
2 EX-2.5 amrx2021311210-kexx25.htm EX-2.5 328642
3 EX-21.1 amrx2021311210-kexx211.htm EX-21.1 19292
4 EX-23.1 amrx-2021123110xkexx231.htm EX-23.1 3735
5 EX-31.1 amrx-2021123110xkexx311.htm EX-31.1 10817
6 EX-31.2 amrx-2021123110xkexx312.htm EX-31.2 10803
7 EX-31.3 amrx-2021123110xkexx313.htm EX-31.3 10871
8 EX-32.1 amrx-2021123110xkexx321.htm EX-32.1 5820
9 EX-32.2 amrx-2021123110xkexx322.htm EX-32.2 5747
10 EX-32.3 amrx-2021123110xkexx323.htm EX-32.3 5958
16 amrx-20211231_g1.jpg GRAPHIC 257394
  Complete submission text file 0001723128-22-000006.txt   20709847

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20211231.xsd EX-101.SCH 136804
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20211231_cal.xml EX-101.CAL 164100
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20211231_def.xml EX-101.DEF 730589
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20211231_lab.xml EX-101.LAB 1444003
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20211231_pre.xml EX-101.PRE 1035015
149 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20211231_htm.xml XML 3850579
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38485 | Film No.: 22698967
SIC: 2834 Pharmaceutical Preparations